Sotera Health Company (SHC)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$15.50
-1.99%
Mkt Cap $4.43B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 24, 2026 | $299.48M | $303.44M | +1.32% | $0.24 | $0.26 | +8.33% | — | — |
| Q4 2025 Nov 4, 2025 | $299.56M | $311.31M | +3.92% | $0.22 | $0.26 | +18.18% | — | — |
| Q3 2025 Aug 8, 2025 | $304.99M | $294.34M | -3.49% | $0.17 | $0.20 | +17.65% | — | — |
| Q2 2025 May 1, 2025 | $276.95M | $254.52M | -8.10% | $0.12 | $0.14 | +16.67% | — | — |
| Q1 2025 Feb 27, 2025 | $259.69M | $290.20M | +11.75% | $0.21 | $0.21 | +0.00% | — | — |
| Q4 2024 Nov 5, 2024 | $291.83M | $285.47M | -2.18% | $0.19 | $0.17 | -10.53% | — | — |
| Q3 2024 Aug 5, 2024 | $266.44M | $276.59M | +3.81% | $0.17 | $0.19 | +11.76% | — | — |
| Q2 2024 May 2, 2024 | $244.56M | $248.18M | +1.48% | $0.14 | $0.13 | -7.14% | — | — |
| Q1 2024 Feb 27, 2024 | $302.15M | $310.24M | +2.68% | $0.26 | $0.26 | +0.00% | — | — |
| Q4 2023 Nov 1, 2023 | $299.08M | $263.18M | -12.00% | $0.21 | $0.21 | +0.00% | — | — |
| Q3 2023 Aug 3, 2023 | $258.93M | $255.28M | -1.41% | $0.18 | $0.21 | +16.67% | — | — |
| Q2 2023 May 3, 2023 | $221.03M | $220.59M | -0.20% | $0.14 | $0.13 | -7.14% | — | — |
| Q1 2023 Feb 28, 2023 | $247.46M | $251.59M | +1.67% | $0.22 | $0.25 | +13.64% | — | — |
| Q4 2022 Nov 2, 2022 | $248.20M | $248.70M | +0.20% | $0.22 | $0.23 | +4.55% | — | — |
| Q3 2022 Aug 4, 2022 | $256.30M | $266.64M | +4.03% | $0.24 | $0.27 | +12.50% | — | — |
| Q2 2022 May 5, 2022 | $230.17M | $236.75M | +2.86% | $0.19 | $0.22 | +15.79% | — | — |
| Q1 2022 Mar 1, 2022 | $236.37M | $241.25M | +2.06% | $0.22 | $0.23 | +4.55% | — | — |
| Q4 2021 Nov 10, 2021 | $214.26M | $226.16M | +5.56% | $0.20 | $0.21 | +5.00% | — | — |
| Q3 2021 Aug 12, 2021 | $251.92M | $251.92M | +0.00% | $0.21 | $0.26 | +23.81% | — | — |
| Q2 2021 May 13, 2021 | $185.63M | $212.15M | +14.29% | $0.16 | $0.18 | +12.50% | — | — |